Observations placeholder
Tranylcypromine Sulfate
Identifier
020231
Type of Spiritual Experience
Background
A description of the experience
Tranylcypromine (INN, USAN, BAN) (brand names: Parnate, Jatrosom (which is a brand solely sold in Germany)) is a monoamine oxidase inhibitor (MAOI)—it is a nonselective and irreversible inhibitor of the enzyme monoamine oxidase (MAO). It is used as an antidepressant and anxiolytic agent in the clinical treatment of mood and anxiety disorders, respectively.
Adverse effects
Adverse effects of tranylcypromine may include anxiety or nervousness, irritability, anorexia and subsequent weight loss, insomnia, mydriasis, tachycardia, hypertension or hypotension, hyperthermia, increased perspiration, muscle tremors, sexual dysfunction consisting of erectile dysfunction and/or anorgasmia, and orthostatic or postural hypotension.
Tranylcypromine is typically considered to have fewer side effects than the hydrazines, such as phenelzine (Nardil).
At least one case of the abuse of tranylcypromine has been noted. Sequelae included the periodic elimination of REM sleep and substantially elevated nocturnal muscle tone. Attempts to discontinue the medication resulted in nightmares accompanied by prompt and grossly excessive nocturnal REM sleep, and narcolepsy
On Jan, 16, 2016: 119 people reported to have side effects when taking Tranylcypromine sulfate. Among them, 4 people (3.36%) have Hallucination.
On Feb, 7, 2016: 119 people reported to have side effects when taking Tranylcypromine sulfate. Among them, 1 people (0.84%) has Death.